EG18109A - Process for preparing flavone derivatives - Google Patents

Process for preparing flavone derivatives

Info

Publication number: EG18109A
Authority: EG; Egypt
Prior art keywords: flavone derivatives; preparing flavone; preparing; derivatives; flavone
Prior art date: 1985-10-22

Application number

EG662/86A

Original Assignee

Recordati Chem Pharm

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1985-10-22

Filing date

1986-10-22

Publication date

1992-08-30

1986-10-22 Application filed by Recordati Chem Pharm filed Critical Recordati Chem Pharm

1992-08-30 Application granted granted Critical

1992-08-30 Publication of EG18109A publication Critical patent/EG18109A/en

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
- C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Diabetes (AREA)
Hematology (AREA)
Cardiology (AREA)
Obesity (AREA)
Heart & Thoracic Surgery (AREA)
Vascular Medicine (AREA)
Endocrinology (AREA)
Rheumatology (AREA)
Urology & Nephrology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Hydrogenated Pyridines (AREA)
Plural Heterocyclic Compounds (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

EG662/86A 1985-10-22 1986-10-22 Process for preparing flavone derivatives EG18109A (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
IT22578/85A IT1190405B (en)	1985-10-22	1985-10-22	FLAVONE DERIVATIVES

Publications (1)

Publication Number	Publication Date
EG18109A true EG18109A (en)	1992-08-30

Family

ID=11198039

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EG662/86A EG18109A (en)	1985-10-22	1986-10-22	Process for preparing flavone derivatives

Country Status (26)

Country	Link
US (1)	US4806534A (en)
EP (1)	EP0223744B1 (en)
JP (1)	JPH0772186B2 (en)
KR (1)	KR910009269B1 (en)
CN (1)	CN86107544A (en)
AR (1)	AR243883A1 (en)
AT (1)	ATE73453T1 (en)
AU (1)	AU596382B2 (en)
CA (1)	CA1330994C (en)
DE (1)	DE3684244D1 (en)
DK (1)	DK169408B1 (en)
EG (1)	EG18109A (en)
ES (1)	ES2002425A6 (en)
FI (1)	FI89167C (en)
GR (1)	GR862546B (en)
HU (1)	HU202863B (en)
IE (1)	IE58330B1 (en)
IL (1)	IL80229A0 (en)
IT (1)	IT1190405B (en)
NO (1)	NO167570C (en)
NZ (1)	NZ217964A (en)
PH (1)	PH22766A (en)
PT (1)	PT83604B (en)
SG (1)	SG55192G (en)
TN (1)	TNSN86144A1 (en)
ZA (1)	ZA867941B (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4912223A (en) *	1988-01-28	1990-03-27	Nelson Research & Development Co.	1,4-Dihydropyridines
US5580751A (en) *	1990-09-14	1996-12-03	Carlsberg A/S	Process for the preparation of C-terminally amidated peptides
US5244602A (en) *	1990-12-03	1993-09-14	Ppg Industries, Inc.	Photochromic naphthopyrans
DE4321030A1 (en) *	1993-06-24	1995-01-05	Bayer Ag	4-bicyclically substituted dihydropyridines, process for their preparation and their use in medicinal products
SE9703377D0 (en) *	1997-09-18	1997-09-18	Astra Ab	New compounds
KR100392468B1 (en) *	2000-09-18	2003-07-22	주식회사 엘지생명과학	3-Hydroxychromene-4-on derivatives useful as cyclin dependendent kinase inhibitors
JP4280067B2 (en)	2001-01-16	2009-06-17	アストラゼネカ・アクチエボラーグ	Heterocyclic compounds for treatment
DE102005034267A1 (en) *	2005-07-22	2007-01-25	Bayer Healthcare Ag	New 4-chromenonyl-1,4-dihydropyridine derivatives, useful for treatment of e.g. aldosteronism, hypertension and cardiac insufficiency, are antagonists of the mineralcorticoid receptor
DE102005034264A1 (en) *	2005-07-22	2007-02-01	Bayer Healthcare Ag	4-Chromenonyl-1,4-dihydropyridinecarbonitriles and their use
CN103254122B (en) *	2013-06-19	2015-04-22	湖南师范大学	Preparation method of cardiovascular drug nilvadipine
AR121719A1 (en)	2020-04-03	2022-06-29	Petra Pharma Corp	ALLESTERIC INHIBITORS OF CHROMENONE OF PHOSPHOINOSITIDE 3-KINASE (PI3K) FOR THE TREATMENT OF DISEASES
TW202309003A (en)	2021-05-03	2023-03-01	美商佩特拉製藥公司	Allosteric chromenone inhibitors of phosphoinositide 3-kinase (pi3k) for the treatment of disease
TWI829179B (en)	2021-05-27	2024-01-11	美商佩特拉製藥公司	Allosteric chromenone inhibitors of phosphoinositide 3-kinase (pi3k) for the treatment of disease
TW202329930A (en)	2021-09-30	2023-08-01	美商佩特拉製藥公司	Allosteric chromenone inhibitors of phosphoinositide 3-kinase (pi3k) for the treatment of disease
CN115536644B (en) *	2022-09-27	2024-09-03	广西民族大学	Application of chromone-2-formamide compound in preparation of hypoglycemic drugs and preparation method thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US2921070A (en) *	1957-11-05	1960-01-12	Recordati Lab Farmacologico S	Basic esters of 3-methylflavone-8-carboxylic acid
NZ201395A (en) *	1981-07-30	1987-02-20	Bayer Ag	Pharmaceutical compositions containing 1,4-dihydropyridines and certain of these dihydropyridines
DE3311005A1 (en) *	1983-03-25	1984-09-27	Bayer Ag, 5090 Leverkusen	CHROMON- AND THIOCHROMONE-SUBSTITUTED 1,4-DIHYDROPYRIDINE DERIVATIVES, SEVERAL PROCESSES FOR THEIR PRODUCTION AND THEIR USE IN MEDICINAL PRODUCTS

1985
- 1985-10-22 IT IT22578/85A patent/IT1190405B/en active
1986
- 1986-10-03 IL IL80229A patent/IL80229A0/en not_active IP Right Cessation
- 1986-10-14 GR GR862546A patent/GR862546B/en unknown
- 1986-10-15 NO NO864108A patent/NO167570C/en unknown
- 1986-10-15 AR AR86305576A patent/AR243883A1/en active
- 1986-10-16 NZ NZ217964A patent/NZ217964A/en unknown
- 1986-10-20 ZA ZA867941A patent/ZA867941B/en unknown
- 1986-10-20 AT AT86830300T patent/ATE73453T1/en not_active IP Right Cessation
- 1986-10-20 EP EP86830300A patent/EP0223744B1/en not_active Expired - Lifetime
- 1986-10-20 ES ES8602677A patent/ES2002425A6/en not_active Expired
- 1986-10-20 DE DE8686830300T patent/DE3684244D1/en not_active Expired - Fee Related
- 1986-10-21 CA CA000520953A patent/CA1330994C/en not_active Expired - Fee Related
- 1986-10-21 HU HU864363A patent/HU202863B/en not_active IP Right Cessation
- 1986-10-21 FI FI864260A patent/FI89167C/en not_active IP Right Cessation
- 1986-10-21 JP JP61251553A patent/JPH0772186B2/en not_active Expired - Lifetime
- 1986-10-21 IE IE276886A patent/IE58330B1/en not_active IP Right Cessation
- 1986-10-21 TN TNTNSN86144A patent/TNSN86144A1/en unknown
- 1986-10-22 DK DK506386A patent/DK169408B1/en not_active IP Right Cessation
- 1986-10-22 PH PH34400A patent/PH22766A/en unknown
- 1986-10-22 AU AU64273/86A patent/AU596382B2/en not_active Ceased
- 1986-10-22 KR KR1019860008836A patent/KR910009269B1/en not_active IP Right Cessation
- 1986-10-22 EG EG662/86A patent/EG18109A/en active
- 1986-10-22 US US06/921,397 patent/US4806534A/en not_active Expired - Fee Related
- 1986-10-22 PT PT83604A patent/PT83604B/en not_active IP Right Cessation
- 1986-10-22 CN CN198686107544A patent/CN86107544A/en active Pending
1992
- 1992-05-23 SG SG551/92A patent/SG55192G/en unknown

Also Published As

Publication number	Publication date
DK506386D0 (en)	1986-10-22
FI864260A (en)	1987-04-23
NZ217964A (en)	1990-04-26
KR870004022A (en)	1987-05-07
NO864108D0 (en)	1986-10-15
KR910009269B1 (en)	1991-11-08
DE3684244D1 (en)	1992-04-16
AU6427386A (en)	1987-04-30
PT83604A (en)	1986-11-01
ATE73453T1 (en)	1992-03-15
FI864260A0 (en)	1986-10-21
HUT45525A (en)	1988-07-28
FI89167C (en)	1993-08-25
CA1330994C (en)	1994-07-26
PT83604B (en)	1988-10-14
EP0223744B1 (en)	1992-03-11
CN86107544A (en)	1987-11-25
PH22766A (en)	1988-12-12
JPS62161781A (en)	1987-07-17
NO864108L (en)	1987-04-23
AU596382B2 (en)	1990-05-03
JPH0772186B2 (en)	1995-08-02
DK169408B1 (en)	1994-10-24
NO167570C (en)	1991-11-20
IE58330B1 (en)	1993-09-08
IT1190405B (en)	1988-02-16
EP0223744A3 (en)	1988-09-14
IL80229A0 (en)	1987-01-30
FI89167B (en)	1993-05-14
HU202863B (en)	1991-04-29
ES2002425A6 (en)	1988-08-01
AR243883A1 (en)	1993-09-30
TNSN86144A1 (en)	1990-01-01
SG55192G (en)	1992-07-24
DK506386A (en)	1987-04-23
EP0223744A2 (en)	1987-05-27
US4806534A (en)	1989-02-21
IE862768L (en)	1987-04-22
IT8522578A0 (en)	1985-10-22
ZA867941B (en)	1987-06-24
NO167570B (en)	1991-08-12
GR862546B (en)	1987-03-04

Publication	Publication Date	Title
YU116787A (en)	1988-04-30	Process for obtaining imidazochynolinic derivatives
PT86120A (en)	1987-12-01	Process for preparing n9-cyclopentyl-adenine derivatives
YU183586A (en)	1988-04-30	Process for obtaining chynoline derivatives
HUT40454A (en)	1986-12-28	Process for preparing 4-substituted androstene-dione derivatives
PT82850A (en)	1986-07-01	Process for preparing furanone derivatives
PT85719A (en)	1987-10-01	Process for preparing 2-amino-ethylamine derivatives
HUT40431A (en)	1986-12-28	Process for preparing piperidine derivatives
PT83820A (en)	1986-12-01	Process for preparing thioxanthone derivatives
HUT42441A (en)	1987-07-28	Process for preparing indolyl- and indazolyl-carboxamide derivatives
EG18109A (en)	1992-08-30	Process for preparing flavone derivatives
YU210187A (en)	1988-10-31	Process for obtaining imidazolylalkylguanidinic derivatives
HUT42082A (en)	1987-06-29	Process for preparing quinolone derivatives
HUT41768A (en)	1987-05-28	Process for producing diphenyl-piperidine derivatives
HUT42500A (en)	1987-07-28	New process for preparing sphyngosine derivatives
HUT42502A (en)	1987-07-28	Process for preparing new erythromycine derivatives
HUT40416A (en)	1986-12-28	Process for preparing dihydro-pyridine derivatives
HUT42079A (en)	1987-06-29	Process for preparing new tannin derivatives
PT81987A (en)	1986-03-01	Process for preparing antihypertensive dihydropiridine derivatives
HUT43617A (en)	1987-11-30	Process for producing gonatriene derivatives
PT81988A (en)	1986-03-01	Process for preparing novel alkylamino-furanone derivatives
PT84553A (en)	1987-04-01	Process for preparing indenopyrimidine derivatives
HUT42432A (en)	1987-07-28	Process for preparing substituted phenyl-carbamide derivatives
HUT44238A (en)	1988-02-29	Process for preparing 1-aryl-5-amino-pyrazole derivatives
HUT40412A (en)	1986-12-28	Process for preparing dihydropyridine derivatives
GR862191B (en)	1986-12-23	Method for preparing novel hydropyridin derivatives